Annual FCF
-$49.55 M
+$17.50 M+26.10%
December 31, 2023
Summary
- As of February 7, 2025, ACHL annual free cash flow is -$49.55 million, with the most recent change of +$17.50 million (+26.10%) on December 31, 2023.
- During the last 3 years, ACHL annual FCF has fallen by -$12.45 million (-33.56%).
- ACHL annual FCF is now -228.49% below its all-time high of -$15.08 million, reached on December 31, 2019.
Performance
ACHL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
N/A
September 1, 2024
Summary
- ACHL quarterly free cash flow is not available.
Performance
ACHL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM FCF
N/A
September 1, 2024
Summary
- ACHL TTM free cash flow is not available.
Performance
ACHL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ACHL Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.1% | - | - |
| 3 y3 years | -33.6% | - | - |
| 5 y5 years | -228.5% | - | - |
ACHL Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.1% | ||||
| 5 y | 5-year | -228.5% | +26.1% | ||||
| alltime | all time | -228.5% | +26.1% |
Achilles Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$18.20 M(-0.6%) | -$18.20 M(-71.0%) |
| Dec 2023 | -$49.55 M(-26.1%) | - | - |
| Mar 2023 | - | -$18.31 M(-14.3%) | -$62.86 M(-6.2%) |
| Dec 2022 | -$67.05 M(+0.2%) | -$21.36 M(+323.0%) | -$67.05 M(+8.2%) |
| Sep 2022 | - | -$5.05 M(-72.2%) | -$61.98 M(-7.8%) |
| Jun 2022 | - | -$18.14 M(-19.3%) | -$67.25 M(-3.7%) |
| Mar 2022 | - | -$22.50 M(+38.1%) | -$69.82 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$66.92 M(+80.4%) | -$16.29 M(+57.9%) | -$66.92 M(+32.2%) |
| Sep 2021 | - | -$10.32 M(-50.2%) | -$50.63 M(+25.6%) |
| Jun 2021 | - | -$20.71 M(+5.7%) | -$40.31 M(+105.7%) |
| Mar 2021 | - | -$19.60 M(+172.7%) | -$19.60 M(+172.7%) |
| Dec 2020 | -$37.10 M(+145.9%) | - | - |
| Mar 2020 | - | -$7.19 M | -$7.19 M |
| Dec 2019 | -$15.08 M | - | - |
FAQ
- What is Achilles Therapeutics annual free cash flow?
- What is the all time high annual FCF for Achilles Therapeutics?
- What is Achilles Therapeutics annual FCF year-on-year change?
- What is the all time high quarterly FCF for Achilles Therapeutics?
- What is the all time high TTM FCF for Achilles Therapeutics?
What is Achilles Therapeutics annual free cash flow?
The current annual FCF of ACHL is -$49.55 M
What is the all time high annual FCF for Achilles Therapeutics?
Achilles Therapeutics all-time high annual free cash flow is -$15.08 M
What is Achilles Therapeutics annual FCF year-on-year change?
Over the past year, ACHL annual free cash flow has changed by +$17.50 M (+26.10%)
What is the all time high quarterly FCF for Achilles Therapeutics?
Achilles Therapeutics all-time high quarterly free cash flow is -$5.05 M
What is the all time high TTM FCF for Achilles Therapeutics?
Achilles Therapeutics all-time high TTM free cash flow is -$7.19 M